Human papillomavirus: A cause of some head and neck cancers?

Medical Journal of Australia

Volumn 181, Issue 8, 2004, Pages 415-416

  Rose, Barbara R ^a,b   Li, Wei ^a,b   O'Brien, Christopher J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN E6; PROTEIN E7; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN; VIRUS DNA; VIRUS VACCINE;

CANCER RISK; CLINICAL TRIAL; DNA DETERMINATION; EDITORIAL; GENE MUTATION; GENITAL TRACT INFECTION; HEAD AND NECK CANCER; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; PROGNOSIS; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO; TONSIL CANCER; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; VIRUS CAPSID; VIRUS GENOME; VIRUS ONCOGENE; WART VIRUS;

EID: 7044230021     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06362.x     Document Type: Editorial

References (15)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841.
2. Tracey EA, Supramaniam R, Chen W. Cancer in New South Wales: incidence and mortality 2001. Sydney: Cancer Council NSW, 2003.
3. Castellsague X, Quintana MJ, Martinez MC, et al. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer 2004; 108: 741-749.
4. Garrote LF, Herrero R, Reyes RM, et al. Risk factors for cancer of the oral cavity and oropharynx in Cuba. Br J Cancer 2001; 85: 46-54.
5. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
6. Klussmann JP, Gultekin E, Weissenborn SJ, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 747-753.
7. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004; 57: 449-455.
8. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95: 1772-1783.
9. Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001; 92: 2875-2884.
10. Mellin H, Dahlgren L, Munck-Wikland E, et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 2002; 102: 152-158.
11. Li W, Thompson CH, O'Brien CJ, et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 2003; 106: 553-558.
12. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 1998; 90: 1626-1636.
13. Li W, Thompson CH, Cossart YE, et al. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 2004; 26: 1-9.
14. Li W, Thompson CH, Xin D, et al. Absence of human papillomavirus in tonsillar squamous cell carcinomas from Chinese patients. Am J Pathol 2003; 163: 2185-2189.
15. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347: 1645-1651.